This application lists 6 specific aims intended to further define the anatomy, biochemistry and physiology of a peptide-containing neural projection arising from the first trigeminal division and protecting to cranial arteries. A multidisciplinary approach will explore these aims using (a) retrograde axonal transport studies and immunohistochemistry (IHC) to determine neural connectivity between perivascular sensory fibers surrounding cranial arteries, cell bodies in trigeminal ganglia and central endings in brain stem, (b) IHC and radioimmunoassay (RIA) (with and without neurosurgical lesions) to identify biochemically, putative transmitter substances in these fibers, (c) IHC plus electron microscopy to describe their ultrastructural characteristics, (d) 14C 2-deoxyglucose method to study the activation of trigeminovascular fibers (by intraluminal vasodistension via balloon-tipped catheter) on the metabolism of discrete brain regions. Animal models will be developed to study the effects of activating the trigeminovascular system on vascular pathophysiology such as perivascular inflammation; these will include models of induced injury such as by chemicals. The effects of neurotransmitter receptor blockers and lesioning the trigeminovascular system on the natural history of induced injuries will be examined. Preliminary evidence suggests that destruction of these nerve fibers significantly modifies the development of chemically-induced brain inflammation. By taking such an approach, we hope to explore possible roles for the trigeminovascular system in response to brain injury and its vasculature, and develop treatments which would be expected to block the development of these changes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS021558-01
Application #
3402767
Study Section
Neurology A Study Section (NEUA)
Project Start
1985-02-01
Project End
1988-01-31
Budget Start
1985-02-01
Budget End
1986-01-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
Bove, G M; Moskowitz, M A (1997) Primary afferent neurons innervating guinea pig dura. J Neurophysiol 77:299-308
Limmroth, V; Lee, W S; Moskowitz, M A (1996) GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges. Br J Pharmacol 117:99-104
Limmroth, V; Cutrer, F M; Moskowitz, M A (1996) Neurotransmitters and neuropeptides in headache. Curr Opin Neurol 9:206-10
Cutrer, F M; Moskowitz, M A (1996) Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain. Headache 36:579-85
Yu, X J; Waeber, C; Castanon, N et al. (1996) 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors. Mol Pharmacol 49:761-5
Weber, J R; Angstwurm, K; Bove, G M et al. (1996) The trigeminal nerve and augmentation of regional cerebral blood flow during experimental bacterial meningitis. J Cereb Blood Flow Metab 16:1319-24
Cutrer, F M; Moussaoui, S; Garret, C et al. (1995) The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation. Neuroscience 64:741-50
Cutrer, F M; Limmroth, V; Ayata, G et al. (1995) Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 116:3199-204
Cutrer, F M; Schoenfeld, D; Limmroth, V et al. (1995) Suppression by the sumatriptan analogue, CP-122,288 of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin. Br J Pharmacol 114:987-92
Lee, W S; Limmroth, V; Ayata, C et al. (1995) Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. Br J Pharmacol 116:1661-7

Showing the most recent 10 out of 40 publications